Position in ICLR
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,443,703
+$704,937 QoQ
Shares Held
8,311
+24.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#192
of 422 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $56,202,312 across 19 Diagnostics & Research names. ICLR ranks #9 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
45,487 | $22,805,362 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
40,470 | $7,819,613 | |
| 3 | DHR |
Danaher Corp /De/
|
29,086 | $5,540,301 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,492 | $3,283,529 | |
| 5 | LH |
Labcorp Holdings Inc.
|
11,187 | $3,132,360 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4,300 | $2,263,692 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
3,996 | $2,116,241 | |
| 8 | A |
Agilent Technologies, Inc.
|
11,896 | $1,580,145 |
All Filings in ICLR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,443,703 | 8,311 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $738,766 | 6,676 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $788,648 | 4,328 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $734,650 | 4,198 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $270,973 | 1,863 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $305,182 | 1,744 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $385,656 | 1,839 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $503,654 | 1,753 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $608,758 | 1,942 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $801,576 | 2,386 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $548,023 | 1,936 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $448,175 | 1,820 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $490,892 | 1,962 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $444,480 | 2,081 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $390,442 | 2,010 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $356,165 | 1,938 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $427,332 | 1,972 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $651,829 | 2,680 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $769,604 | 2,485 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $585,614 | 2,235 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $736,301 | 3,562 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $902,909 | 4,598 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $574,606 | 2,947 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $565,817 | 2,961 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $512,118 | 3,040 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $427,040 | 3,140 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||